Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (584,994)	$ (4,879,647)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	0	110,365
Amortization of intangible assets	13,919	48,285
Amortization of debt discount	16,789	269,028
Stock-based compensation	280,919	433,180
Issuance of common stock for services	2,000	132,247
Change in fair value of derivatives	22,700	(503,284)
Accrued interest expenses on notes payable	58,641	71,739
Inducement for exercise of warrants	0	3,560,958
Extinguishment of convertible debt	0	(288,618)
Provision for bad debt	35,211	26,526
Changes in operating assets and liabilities:
Accounts receivable	(83,925)	(144,426)
Customer short-term notes receivable	20,191	47,231
Customer long-term notes receivable	7,777	77,258
Deferred revenue	(8,578)	(90,133)
Prepaid insurance	14,123	3,675
Accounts payable and accrued liabilities	(2,976)	(411,127)
Net cash used in operating activities	(208,203)	(959,507)
Cash flows from investing activities:
Payment of deferred acquisition payable - intellectual Capital Mgmt, LLC	0	(10,000)
Software development costs	0	(179,647)
Net cash used in investing activities	0	(189,647)
Cash flows from financing activities:
Net proceeds from warrant exercises related to tender offer	0	1,179,252
Repayment of notes payable	0	(70,262)
Repayment of notes to former CEO	0	(35,000)
Repayment of convertible notes	0	(200,000)
Proceeds from issuance of convertible debt	319,000	0
Net cash provided by financing activities	319,000	873,990
Net increase (decrease) in cash and cash equivalents	110,797	(275,164)
Cash and cash equivalents at beginning of the period	74,523	470,341
Cash and cash equivalents at end of the period	$ 185,320	$ 195,177